Pediatr. praxi. 2016;17(4):224-227 | DOI: 10.36290/ped.2016.052
Familial hypercholesterolemia in children
- Pediatrická klinika LF MU a FN Brno
Familial hypercholesterolemia (FH) is a serious genetic condition increasing significantly cardiovascular risk. Early diagnosis and
intensive treatment may revert the premature atherothrombotic vascular complication risk. The treatment of FH is based on
therapeutic lifestyle changes and necessarily also on pharmacotherapy.
Keywords: childhood, screening, familial hypercholesterolemia, hypolipidemic therapy, prevention
Published: October 1, 2016 Show citation
References
- Berenson GS, Srinivasan SR. Prevention of atherosclerosis in childhood. Lancet, 1999; 354(9): 1223-1224.
Go to original source... - Češka R, Freiberger T, Urbanová Z. Familiární hypercholesterolemie. Triton: Praha 2015: 157 s.
- Stary HC. Evolution and progression of atherosclerotic lessions in coronary arteries of children and young adults. Arteriosclerosis, 1989; 9(Suppl 1): 19-32.
- Daniels SR, Gidding SS, de Ferrantu SD. Pediatrc aspects of familial hypercholesterolemias: recomendations from the National lipid Association Expert Panel on Familial Hypercholesterolemia. J. Clin. Lipidol. 2011; 5: S30-37. Go to original source...
Go to PubMed... - Descamps OS, Tenoutasse S, Stephenne X, et al. Management of familial hypercholesterolemiea in children and young adults: Consensus paper developer by a panel of lipidologists, cardiologists, nutritionists, gastroenterologists, general practitioners and a parent organization. Atheroslerosis 2011; 12(2): 221-263. Go to original source...
- Tichý L, Freiberger T, Zapletalová P, et al. The molecular basis of familial hypercholesterolemia in the Czech Republic: Spectrum of LDLR mutations and genotype-phenotype correlations. Aterosclerosis 2012; 223(2): 401-408. Go to original source... Go to PubMed...
- Vráblík M, Schwarzová L, Freiberger T, et al. Familární hypercholesterolemie: klinické nálezy, molekulární genetika a diferenciální diagnostika. AtheroRev 2016; 1(1): 19-27.
- Stožický F, Kopečná L. Dyslipoproteinémie u dětí. IDVPZ Brno 2002: 1-59.
- Češka R. Současný pohled na léčbu hypercholesterolémie. Farmakoterapie 2014; Suppl 4: 5-11.
- Kopečná L, Bauerová H, Homolová D. Hyperlipoproteinémie u dětí - diagnostika a terapie. IDVPZ, Brno 2002: 1-100.
- Goldgerg AC, Hopkins PN, Toth PP, et al. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatrics and adult patiens: Clinical Guyance from the National Lipid Association Expert Panel on Familial Hypercholesterolemie. J. Clin. Lipidol 2011; 5(3): 133-140. Go to original source... Go to PubMed...
- Tomandlová M, Kopečná L. Vitamin A, vitamin E u dětí s hypercholesterolémií. Chem. Listy, 2000; 94(8): 656.
- Bláha V. Regulace vnitrobuněčného metabolismu LDL-cholesterolu: význam inhibice PCSK9. Farmakoterapie 2014; 10(Supppl. 4): 12-16.
- Freiberger T, Vráblík M. 15 let projektu MedPed v České republice. Hypertenze a KV prevence 2013; 2: 58-60.